Literature DB >> 4321474

Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanism.

H E Williams, L H Smith.   

Abstract

The effect of hydroxypyruvate on synthesis of oxalate and glycolate from glyoxylate was studied in in vitro preparations from normal human erythrocytes and leukocytes, rat liver, and with purified lactate dehydrogenase from beef heart. In the presence of reduced nicotinamide adenine dinucleotide, hydroxypyruvate stimulated the oxidation of glyoxylate to oxalate and decreased the reduction of glyoxylate to glycolate. These findings may explain the hyperoxaluria seen in L-glyceric aciduria (type II primary hyperoxaluria).

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4321474     DOI: 10.1126/science.171.3969.390

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

Review 1.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

2.  Combined Liver-Kidney Transplantation for Primary Hyperoxaluria Type 2: A Case Report.

Authors:  T Dhondup; E C Lorenz; D S Milliner; J C Lieske
Journal:  Am J Transplant       Date:  2017-08-14       Impact factor: 8.086

3.  Enzymological characterization of a feline analogue of primary hyperoxaluria type 2: a model for the human disease.

Authors:  C J Danpure; P R Jennings; J Mistry; R A Chalmers; R E McKerrell; W F Blakemore; M F Heath
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  'Gelbsilber' rabbits: a closed colony of high responders to the lactic dehydrogenase isoenzyme LDH-H4. Possible mechanisms controlling the response.

Authors:  F Falkenberg; A Frensdorff
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

5.  Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.

Authors:  Chengjung Lai; Natalie Pursell; Jessica Gierut; Utsav Saxena; Wei Zhou; Michael Dills; Rohan Diwanji; Chaitali Dutta; Martin Koser; Naim Nazef; Rachel Storr; Boyoung Kim; Cristina Martin-Higueras; Eduardo Salido; Weimin Wang; Marc Abrams; Henryk Dudek; Bob D Brown
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

6.  Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.

Authors:  Gema Ariceta; Kelly Barrios; Bob D Brown; Bernd Hoppe; Ralf Rosskamp; Craig B Langman
Journal:  Kidney Int Rep       Date:  2021-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.